Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1593453

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1593453

Positron Emission Tomography Market Size, Share, Growth Analysis, By Product, By Application, By End User, By Region - Industry Forecast 2024-2031

PUBLISHED:
PAGES: 204 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Positron Emission Tomography Market size was valued at USD 2.35 billion in 2022 and is poised to grow from USD 2.52 billion in 2023 to USD 4.21 billion by 2031, growing at a CAGR of 6.61% during the forecast period (2024-2031).

The rising prevalence of life-threatening conditions like cancer and Alzheimer's disease has significantly fueled the demand for PET scans, which are essential for advanced imaging technologies that aid in diagnosis and ongoing patient care. These scans provide crucial insights into the physiological and metabolic processes within the body, enabling healthcare professionals to effectively assess and manage chronic conditions, ultimately improving patient outcomes and treatment success. As chronic illnesses continue to rise, there is an increasing need for targeted therapeutics and personalized medicine, making PET scans invaluable for tailoring treatments to unique patient needs. These imaging techniques have evolved to measure disease progression and therapeutic responses accurately, thanks to advancements in molecular imaging technology and the incorporation of artificial intelligence (AI) and machine learning, which enhance the precision and efficiency of scans. This technological evolution not only facilitates better identification and follow-up of medical conditions but also expands the role of PET scans in both research and clinical diagnostics across various medical specialties. Consequently, the market for PET scans is experiencing robust growth, reflecting their integral role in contemporary healthcare and the drive towards more personalized medical approaches.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Positron Emission Tomography market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Positron Emission Tomography Market Segmental Analysis

Global Positron Emission Tomography Market is segmented by Product, Application, End User, and Region. Based on Product, the market is segmented into Standalone PET Systems, PET/CT Systems (Low-Slice Scanners, Medium-Slice Scanners, High-Slice Scanners), PET/MRI Systems. Based on Application, the market is segmented into Oncology Applications, Neurological Applications, Cardiovascular Applications, Other Applications. Based on End User, the market is segmented into Hospitals & Surgical Centers, Diagnostic & Imaging Clinics, Ambulatory Care Centers, Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Positron Emission Tomography Market

The escalating incidence of chronic diseases, including cancer, Alzheimer's disease, and cardiovascular disorders, serves as a pivotal market driver for the Global Positron Emission Tomography (PET) market. As these conditions necessitate sophisticated imaging techniques for effective diagnosis and ongoing management, PET scans have become vital tools in the healthcare arsenal. They provide critical insights into metabolic and physiological functions, which are essential for formulating tailored treatment plans. The burgeoning patient population suffering from chronic illnesses worldwide enhances the demand for PET technology, thereby propelling market growth. This trend underscores the need for advanced diagnostic modalities to effectively navigate the complexities of chronic disease management.

Restraints in the Global Positron Emission Tomography Market

The Global Positron Emission Tomography (PET) market faces significant restraints primarily due to the prohibitive costs associated with PET scanners. High purchase prices, coupled with substantial operational and maintenance expenses, pose hurdles for smaller medical facilities and diagnostic laboratories with limited budgets. This financial barrier restricts access to advanced imaging technologies, particularly in resource-constrained environments. As a result, the high costs hinder broader adoption and utilization of PET scanning services, ultimately stifling market growth and limiting the expansion of innovative applications that could enhance diagnostic capabilities and improve patient outcomes in the healthcare sector.

Market Trends of the Global Positron Emission Tomography Market

The Global Positron Emission Tomography (PET) market is experiencing significant growth driven by the integration of machine learning and artificial intelligence into scanning technologies. These advancements enhance image capture, reconstruction, and analysis, leading to improved diagnostic accuracy and expedited procedures. AI algorithms facilitate the detection of subtle anomalies and ensure precise tumor characterization, which translates into faster and more effective patient care. Furthermore, the utilization of machine learning to predict patient outcomes facilitates personalized treatment plans based on imaging data. As these technologies evolve, their incorporation into PET systems is poised to transform clinical and research practices, driving market expansion and accessibility.

Product Code: SQMIG35D2276

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factor
  • Degree of Competition
  • Top Investment Pockets
  • Ecosystem of the Market
  • Value Chain Analysis
  • Supply Chain Analysis
  • Patent Analysis
  • Trade Analysis
  • Technology Analysis
  • Regulatory Landscape
  • Case Study Analysis

Positron Emission Tomography Market, By Product

  • Market Overview
  • Standalone PET Systems
  • PET/CT Systems
    • Low-Slice Scanners
    • Medium-Slice Scanners
    • High-Slice Scanners
  • PET/MRI Systems

Positron Emission Tomography Market, By Application

  • Market Overview
  • Oncology Applications
  • Neurological Applications
  • Cardiovascular Applications
  • Other Applications

Positron Emission Tomography Market, By End User

  • Market Overview
  • Hospitals And Surgical Centers
  • Diagnostic And Imaging Clinics
  • Ambulatory Care Centers
  • Other End Users

Positron Emission Tomography Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • General Electric
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Koninklijke Philips N.V.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shanghai United Imaging Healthcare Co., Ltd
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Canon Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shimadzu Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mediso Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MinFound Medical Systems Co., Ltd
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Neusoft Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bruker
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CMR Naviscan
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kindsway Biotech
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hermes Medical Solutions
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sofie Biosciences
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Prescient Medical Imaging
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Reflexion
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cubresa Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Synchropet, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novartis
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Revvity Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!